A comparison of commercially available adjuvants for use in research☆
References (13)
- et al.
Adjuvant activity of non-ionic block copolymers. IV. Effect of molecular weight and formulation on titre and isotype of antibody
Vaccine
(1991) - et al.
Adjuvant activity of non-ionic block copolymers. V. Modulation of antibody isotype by lipopolysaccharides, lipid A and precursors
Vaccine
(1991) Control of animal pain and distress in antibody production and infectious disease studies
J. Am. Vet. Med. Assoc.
(1987)Theory of emulsions: stability
A retrospective review of lesions associated with the use of Freund's adjuvant
Lab. Animal Sci.
(1989)- et al.
Sensitization and antibody formation after injection of tubercle bacilli and paraffin oil
Cited by (114)
Novel adjuvants derived from attenuated lipopolysaccharides and lipid As of purple non-sulfur photosynthetic bacteria
2019, VaccineCitation Excerpt :Slow reduction in the anti-TNP IgG titers, over 4 months after immunization, was observed using either LPS- or lipid A-based adjuvants. Similar results were observed using TiterMax adjuvant, where the duration of the antibody response has been related to the persistence of the antigen [1]. This indicates that the LPS- and lipid A-based adjuvants, used in this study, may provide prolonged high level of anti-TNP IgG antibodies in the serum, indicative of sustained protective response.
Discrimination of Benign and Malignant Lymph Nodes at 7.0T Compared to 1.5T Magnetic Resonance Imaging Using Ultrasmall Particles of Iron Oxide. A Feasibility Preclinical Study
2013, Academic RadiologyCitation Excerpt :In the other three of the six rabbits, complete Freund's adjuvant cell suspension (CFA; Sigma-Aldrich, Steinheim, Germany) was injected into the left thigh muscle to achieve reactively enlarged lymph nodes. CFA is a water-in-oil combination of killed mycobacteria that causes local granulomatosus reactions and lymphadenitis in draining nodes (14) after 10 to 15 days. MRI was performed 2 to 4 weeks following the induction of both reactive or metastatic lymph nodes at 1.5T.
Polyclonal Antibody Production
2012, The Laboratory Rabbit, Guinea Pig, Hamster, and Other RodentsNano-Adjuvants
2023, AAPS Advances in the Pharmaceutical Sciences Series
- ☆
Supported by grant #6-38943 from CytRx Corporation to Emory University. Robert Hunter is Vice President and Director of Research for CytRx Corporation. This study was presented as a poster at the 1991 FASEB Meeting (abstract #1464).